Sciele Pharma (SCRX) Expands Alliance With sanofi-aventis
Sciele Pharma, Inc. (NASDAQ: SCRX) extended its alliance with sanofi-aventis (NYSE: SNY) by entering into a new exclusive, three-year agreement to market Allegra Orally Disintegrating Tablets and Allegra Oral Suspension in the pediatric market in the U.S.
Under the terms of this agreement, Sciele will be responsible for all sales and marketing programs associated with these products in the U.S. and will share revenues on both Allegra OS and ODT. Sciele expects to launch Allegra ODT in March 2008 through its 100 pediatric sales representatives.
Related Categories
FDAStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
